M. A. N. ŞENDUR Et Al. , "Study of the impact of Charlson comorbidity index on the efficacy of aromatase inhibitors in patients with hormone receptor positive postmenopausal breast cancer," 2015 ASCO Annual Meeting , 2015
ŞENDUR, M. A. N. Et Al. 2015. Study of the impact of Charlson comorbidity index on the efficacy of aromatase inhibitors in patients with hormone receptor positive postmenopausal breast cancer. 2015 ASCO Annual Meeting .
ŞENDUR, M. A. N., AKSOY, S., SILAY, K., AKINCI, M. B., ÖZDEMİR, N., YAZICI, O., ... ÖZBEK, S.(2015). Study of the impact of Charlson comorbidity index on the efficacy of aromatase inhibitors in patients with hormone receptor positive postmenopausal breast cancer . 2015 ASCO Annual Meeting
ŞENDUR, MEHMET Et Al. "Study of the impact of Charlson comorbidity index on the efficacy of aromatase inhibitors in patients with hormone receptor positive postmenopausal breast cancer," 2015 ASCO Annual Meeting, 2015
ŞENDUR, MEHMET A. Et Al. "Study of the impact of Charlson comorbidity index on the efficacy of aromatase inhibitors in patients with hormone receptor positive postmenopausal breast cancer." 2015 ASCO Annual Meeting , 2015
ŞENDUR, M. A. N. Et Al. (2015) . "Study of the impact of Charlson comorbidity index on the efficacy of aromatase inhibitors in patients with hormone receptor positive postmenopausal breast cancer." 2015 ASCO Annual Meeting .
@conferencepaper{conferencepaper, author={MEHMET ALİ NAHİT ŞENDUR Et Al. }, title={Study of the impact of Charlson comorbidity index on the efficacy of aromatase inhibitors in patients with hormone receptor positive postmenopausal breast cancer}, congress name={2015 ASCO Annual Meeting}, city={}, country={}, year={2015}}